XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.24.3

EARNINGS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2024
EARNINGS PER SHARE |
EARNINGS PER SHARE | NOTE 4: EARNINGS PER SHARE ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended September 30,
​ | ​ | 2024 |  | 2023
​ | ​ | (In Thousands, Except Per Share Data)
Basic: | ​ | ​ | ​ | ​ | ​ | ​
Average common shares outstanding | ​ |  | 11,656 | ​ |  | 11,935
Net income |  | $ | 16,490 |  | $ | 15,879
Per common share amount |  | $ | 1.41 |  | $ | 1.33
​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted: | ​ | ​ | ​ | ​ | ​ | ​
Average common shares outstanding | ​ | ​ | 11,656 | ​ | ​ | 11,935
Net effect of dilutive stock options – based on the treasury stock method using average market price | ​ | ​ | 63 | ​ | ​ | 42
Diluted common shares | ​ | ​ | 11,719 | ​ | ​ | 11,977
Net income |  | $ | 16,490 |  | $ | 15,879
Per common share amount |  | $ | 1.41 |  | $ | 1.33
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Nine Months Ended September 30,
​ | ​ | 2024 |  | 2023
​ | ​ | (In Thousands, Except Per Share Data)
Basic: | ​ | ​ |  |  | ​ |
Average common shares outstanding | ​ | ​ | 11,688 |  | ​ | 12,055
Net income | ​ | $ | 46,885 | ​ | $ | 54,655
Per common share amount | ​ | $ | 4.01 | ​ | $ | 4.53
​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted: | ​ |  | ​ | ​ |  | ​
Average common shares outstanding | ​ |  | 11,688 | ​ |  | 12,055
Net effect of dilutive stock options – based on the treasury stock method using average market price | ​ |  | 58 | ​ |  | 49
Diluted common shares | ​ |  | 11,746 | ​ |  | 12,104
Net income | ​ | $ | 46,885 | ​ | $ | 54,655
Per common share amount | ​ | $ | 3.99 | ​ | $ | 4.52
​ Options outstanding at September 30, 2024 and 2023, to purchase 712,403 and 758,129 shares of common stock, respectively, were not included in the computation of diluted earnings per common share for each of the three month periods because the exercise prices of such options were greater than the average market price of the common stock for the three months ended September 30, 2024 and 2023, respectively. Options outstanding at September 30, 2024 and 2023, to purchase 712,403 and 675,768 shares of common stock, respectively, were not included in the computation of diluted earnings per common share for each of the nine month periods because the exercise prices of such options were greater than the average market price of the common stock for the nine months ended September 30, 2024 and 2023, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration